Moses Lake Pharmacy Recalls Hydroxocobalamin Syringes Due to Sterility Concerns
JD & SN Inc. is recalling 11 Hydroxocobalamin syringes because the FDA cannot ensure they are sterile. The recall covers units distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in injectable drugs, which poses a significant risk of infection or serious injury.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling 11 unit dose syringes of Hydroxocobalamin (preservative free) Injectable Solution. The product is a 1.5 mg/0.25 mL solution in 20 mL syringes, available by prescription only. The recall was initiated because the FDA cannot assure the sterility of the compounded drugs.
The affected units were distributed nationwide. The recall includes specific lots identified by codes such as t12192014@13 and t11212014@24. The source text indicates that all sterile human compounded drugs within expiry are subject to this lack of assurance of sterility.
Consumers and healthcare providers should stop using the affected syringes and contact the recalling firm or their healthcare provider for further instructions. The recall is classified as Class II by the FDA.
The recalled product
- Product
- HYDROXOCOBALAMIN (PRESERVATIVE FREE) UNIT DOSE SYRINGES, Injectable Solution, 1.5 mg/0.25 mL, 20 mL syringes, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 11
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- t12192014@13
- t11212014@24
- t10022014@24
- t09092014@17
- t06112015@34
- t05182015@12
- t03062015@39
- t03032015@22
- t02202015@18
- t01292015@26
- t01192015@10.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereHydroxocobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- SevereRXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereMoxifloxacin Ophthalmic Injection Syringes Recalled for Sterility Risk
FDA (Drugs) · 2022-02-02
- SevereLiberty Drug Recalls Hydroxocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereFDA Recalls Hydroxocobalamin Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereColonia Care Pharmacy Recalls C-Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-10-09